公开(公告)号：US20240350569A1

公开(公告)日：2024-10-24

申请号：US18763681

申请日：2024-07-03

申请人： Houn Simon Hsia

发明人： Houn Simon Hsia

IPC分类号： A61K36/064 ,  A23L33/105 ,  A23L33/115 ,  A23L33/14 ,  A23L33/15 ,  A23L33/155 ,  A23L33/16 ,  A23L33/175 ,  A61K31/015 ,  A61K31/05 ,  A61K31/122 ,  A61K31/18 ,  A61K31/198 ,  A61K31/202 ,  A61K31/24 ,  A61K31/30 ,  A61K31/32 ,  A61K31/34 ,  A61K31/4415 ,  A61K31/519 ,  A61K31/593 ,  A61K33/18 ,  A61K33/24 ,  A61K33/30 ,  A61K33/32 ,  A61K33/34 ,  A61K35/60 ,  A61K36/06

CPC分类号： A61K36/064 ,  A23L33/105 ,  A23L33/115 ,  A23L33/14 ,  A23L33/15 ,  A23L33/155 ,  A23L33/16 ,  A23L33/175 ,  A61K31/015 ,  A61K31/05 ,  A61K31/122 ,  A61K31/18 ,  A61K31/198 ,  A61K31/202 ,  A61K31/24 ,  A61K31/30 ,  A61K31/32 ,  A61K31/34 ,  A61K31/4415 ,  A61K31/519 ,  A61K31/593 ,  A61K33/18 ,  A61K33/24 ,  A61K33/30 ,  A61K33/32 ,  A61K33/34 ,  A61K35/60 ,  A61K36/06 ,  A23V2002/00

摘要： The present invention provides nutritional compositions that are employed as oral supplementation to the human diet and methods for using such nutritional compositions. The compositions of the present invention provide for supplementation to the diet of the cancer patient, as well as preventative dietary supplementation aimed at supporting the human immune system for those not currently suffering from cancer.

公开(公告)号：US20240350519A1

公开(公告)日：2024-10-24

申请号：US18615236

申请日：2024-03-25

申请人： Quicksilver Scientific, Inc.

发明人： Christopher W. Shade ,  Steven Tieu ,  James R Huey ,  David Durkee ,  Michelle Schwenk

IPC分类号： A61K31/00 ,  A23G3/34 ,  A23G3/36 ,  A23G3/40 ,  A23G3/42 ,  A23G3/44 ,  A23G3/48 ,  A61K9/00 ,  A61K9/107 ,  A61K31/01 ,  A61K31/015 ,  A61K31/045 ,  A61K31/07 ,  A61K31/122 ,  A61K31/197 ,  A61K31/198 ,  A61K31/205 ,  A61K31/355 ,  A61K31/375 ,  A61K31/593 ,  A61K33/30 ,  A61K36/185 ,  A61K36/539 ,  A61K47/10 ,  A61K47/12 ,  A61K47/14 ,  A61K47/24 ,  A61K47/26 ,  A61K47/42 ,  A61K47/44

CPC分类号： A61K31/658 ,  A23G3/0019 ,  A23G3/368 ,  A23G3/40 ,  A23G3/42 ,  A23G3/44 ,  A23G3/48 ,  A61K9/0056 ,  A61K9/1075 ,  A61K31/01 ,  A61K31/015 ,  A61K31/045 ,  A61K31/07 ,  A61K31/122 ,  A61K31/197 ,  A61K31/198 ,  A61K31/205 ,  A61K31/355 ,  A61K31/375 ,  A61K31/593 ,  A61K33/30 ,  A61K36/185 ,  A61K36/539 ,  A61K47/10 ,  A61K47/12 ,  A61K47/14 ,  A61K47/24 ,  A61K47/26 ,  A61K47/42 ,  A61K47/44

摘要： Microemulsions incorporated into gummy confections are described where hydrophobic liquid droplets are distributed in a continuous hydrophilic liquid phase. In relation to conventional oil-in-water (OIW) microemulsions, prior to incorporation into the gummy confections the described microemulsions may be thought of as modified oil-in-water (MOIW) microemulsions, where both the “oil” and “water” phases of the microemulsion are modified. The oil phase droplets of the MOIW microemulsion are modified with alcohol and can better deliver oil-soluble species to the bloodstream than can oil blends or the oil phases of conventional oil-in-water (OIW) microemulsions. The polar continuous “water” phase of the MOIW microemulsion is modified with a sugar or sugar alcohol. The modified oil phase droplets disperse into the modified polar continuous phase of the MOIW microemulsion prior to incorporation into the gummy confection.

公开(公告)号：US20240309289A1

公开(公告)日：2024-09-19

申请号：US18671969

申请日：2024-05-22

申请人： Scientific Holdings, LLC

发明人： Sytze J. Elzinga ,  Jeffrey Charles Raber ,  Bradley J. Douglass

IPC分类号： C11B9/00 ,  A23L5/00 ,  A23L27/10 ,  A23L27/20 ,  A61K31/01 ,  A61K31/015 ,  C11B9/02 ,  C40B30/00 ,  G01N33/00

CPC分类号： C11B9/0007 ,  A23L5/51 ,  A23L27/115 ,  A23L27/202 ,  A23L27/2026 ,  A23L27/203 ,  A61K31/01 ,  A61K31/015 ,  C11B9/0034 ,  C11B9/0038 ,  C11B9/0046 ,  C11B9/0049 ,  C11B9/022 ,  C40B30/00 ,  G01N33/00 ,  A23V2200/15 ,  A23V2200/16 ,  A23V2250/21

摘要： Compositions which are fragrant and contain at least a member set culled from a library of compositions, each being comprised of sub-combinations of selected terpenes. Fragrances that mimic that of various states of organic and synthetic aromatics including products, processes and those from non-combusted plant products, among other things, iniquitous products, processes, medicinals, and related moieties leverage databases of all known terpene groupings are offered for consideration, and have been provided, according to the instant teachings.

公开(公告)号：US12083156B1

公开(公告)日：2024-09-10

申请号：US18517708

申请日：2023-11-22

申请人： KING FAISAL UNIVERSITY

发明人： Munirah Fahad Aldayel

IPC分类号： A61K36/9066 ,  A61K31/015 ,  A61K31/12 ,  A61K36/00 ,  A61P31/06

CPC分类号： A61K36/9066 ,  A61K31/015 ,  A61K31/12 ,  A61P31/06 ,  A61K2236/11 ,  A61K2236/33

摘要： Methods of producing, compositions containing, and methods for administering curcumin, and particularly extracts obtained from a laser irradiated rhizome of Curcuma longa having an enhanced antimicrobial activity. An ethanolic extract of the laser irradiated rhizome of Curcuma longa exhibits increased levels of bisdemethoxycurcumin and curcumin, as well as of alpha-curcumene, (-)-zingiberene, caryophyllene, and beta sesquiphellandrene as compared to those of an ethanolic extract from a Curcuma longa rhizome not irradiated by a laser.

公开(公告)号：US20240285723A1

公开(公告)日：2024-08-29

申请号：US18573517

申请日：2022-06-22

申请人： RAMOT AT TEL-AVIV UNIVERSITY LTD.

发明人： Yankel GABET ,  Josef MOGRABI

IPC分类号： A61K38/08 ,  A61K31/015 ,  A61K31/497 ,  A61K31/566 ,  A61K31/573 ,  A61P31/00 ,  A61P37/06

CPC分类号： A61K38/08 ,  A61K31/015 ,  A61K31/497 ,  A61K31/566 ,  A61K31/573 ,  A61P31/00 ,  A61P37/06

摘要： Pharmaceutical compositions are provided, comprising at least one selective CB2 receptor agonist and at least one steroid. The provided compositions are effective in treating inflammation and/or pathogen related inflammation and associated complications thereof. Also provided are methods for treating a subject infected with a pathogen as well as inflammation, using said compositions.

公开(公告)号：US20240269089A1

公开(公告)日：2024-08-15

申请号：US18624108

申请日：2024-04-01

申请人： Andrea Small-Howard ,  Helen Turner

发明人： Andrea Small-Howard ,  Helen Turner

IPC分类号： A61K31/01 ,  A61K9/00 ,  A61K31/015 ,  A61K31/045 ,  A61K31/05 ,  A61K31/192 ,  A61K31/352 ,  A61K36/185 ,  A61K45/06 ,  A61P29/02

CPC分类号： A61K31/01 ,  A61K9/0014 ,  A61K9/0019 ,  A61K9/006 ,  A61K9/0073 ,  A61K31/015 ,  A61K31/045 ,  A61K31/05 ,  A61K31/192 ,  A61K31/352 ,  A61K36/185 ,  A61K45/06 ,  A61P29/02 ,  A61K2236/51

摘要： Provided herein are pharmaceutical compositions that comprise myrcene, optionally in admixture with cannabinoids and other terpenes, typically substantially free of THC and THCA, for targeting TRPV1 receptors. Also provided are methods of using the pharmaceutical compositions to desensitize TRPV1 receptors in order to treat pain, cardiovascular diseases such as cardiac hypertrophy, overactive bladder, and chronic cough.

公开(公告)号：US20240216319A1

公开(公告)日：2024-07-04

申请号：US18457928

申请日：2023-08-29

申请人： Hal Alper

发明人： Hal Alper

IPC分类号： A61K31/216 ,  A61K31/015 ,  A61K31/122 ,  A61K45/06 ,  A61P35/00

CPC分类号： A61K31/216 ,  A61K31/015 ,  A61K31/122 ,  A61K45/06 ,  A61P35/00

摘要： Antitumor pharmaceutical compositions and methods of treatment for a variety of cancers, in which the antitumor compositions can be used alone or in combination with existing cancer therapies. The antitumor compositions can comprise or consist essentially of a combination of methyl jasmonate, cis-jasmone, and d-limonene. In a further aspect, the antitumor compositions can comprise or consist essentially of any two of methyl jasmonate, cis-jasmone, and d-limonene. Carriers or adjuvants such as squalene can be used with the compositions. This combination of components provides unexpected benefits, including synergistic enhancements cancer treatment and pain management when used with existing cancer therapies.

公开(公告)号：US20240197223A1

公开(公告)日：2024-06-20

申请号：US18555983

申请日：2022-05-30

申请人： GIVAUDAN SA

发明人： Giuliano GAETA ,  Alan Forbes PROVAN ,  Imogen Maria MATHEWS ,  Salla Katja Emilia PARKKINEN

IPC分类号： A61B5/16 ,  A61B5/00 ,  A61B5/1455 ,  A61K31/015 ,  A61K31/11 ,  A61K31/122 ,  A61K31/22 ,  A61K31/222 ,  A61K31/341 ,  A61K31/351 ,  A61K31/366 ,  A61K36/534 ,  A61K36/73 ,  A61K36/752 ,  A61K36/899

CPC分类号： A61B5/165 ,  A61B5/0036 ,  A61B5/1455 ,  A61B5/14553 ,  A61K31/015 ,  A61K31/11 ,  A61K31/122 ,  A61K31/22 ,  A61K31/222 ,  A61K31/341 ,  A61K31/351 ,  A61K31/366 ,  A61K36/534 ,  A61K36/73 ,  A61K36/752 ,  A61K36/899

摘要： The present disclosure relates to methods of assessing the ability of a test oral care flavour ingredient or a test oral care flavour composition to improve the relaxation state of a human subject and of creating oral care flavour compositions having a relaxing effect on a human subject. It further relates to oral care flavour compositions for improving the relaxation state of a human subject, to consumer products comprising such oral care flavour compositions, and to methods of improving the relaxation state of a human subject.

公开(公告)号：US12011420B2

公开(公告)日：2024-06-18

申请号：US18046127

申请日：2022-10-12

申请人： EpiTop, Inc.

发明人： Byung Eui Kim ,  Donald Y. M. Leung

IPC分类号： A61K31/015 ,  A61P31/04

CPC分类号： A61K31/015 ,  A61P31/04

摘要： Provided are a pharmaceutical composition and a method for treating a microbial infection in a subject in need thereof. In some cases, the composition comprises at least about 10% of thujopsene and at least about 10% of totarol. The present disclosure also provides a pharmaceutical composition and a method for treating a viral infection in a subject in need thereof. In some cases, the method comprises administering to the subject in need thereof a therapeutically effective amount of a composition comprising at least about 10% of thujopsene.

公开(公告)号：US20240165029A1

公开(公告)日：2024-05-23

申请号：US18280165

申请日：2022-03-08

申请人： UNIVERSITY OF CONNECTICUT

发明人： Evgueni Pinkhassik ,  Sergey Dergunov ,  Weiyu Zhang

IPC分类号： A61K9/127 ,  A61K31/015 ,  A61K31/047 ,  A61K31/122 ,  A61K31/4704 ,  A61K31/4709 ,  A61K31/7105 ,  A61K31/711 ,  A61K47/06

CPC分类号： A61K9/1278 ,  A61K31/015 ,  A61K31/047 ,  A61K31/122 ,  A61K31/4704 ,  A61K31/4709 ,  A61K31/7105 ,  A61K31/711 ,  A61K47/06

摘要： The present disclosure is concerned with unilamellar liposomes and methods of making same. The disclosed unilamellar liposomes can be useful in, for example, delivering a cargo molecule (e.g., a nucleic acid) and also in inducing an immune response. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.